Health Care & Life Sciences » Pharmaceuticals | Tianjin Zhongxin Pharmaceutical Group Corp. Ltd.

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. | Ownership

Companies that own Tianjin Zhongxin Pharmaceutical Group Corp. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Value Partners Ltd.
4,035,100
2.02%
3,424,900
0.06%
12/31/2017
Affin Hwang Asset Management Bhd.
1,673,600
0.84%
-2,179,600
0.15%
02/28/2018
TIAA-CREF Investment Management LLC
1,636,400
0.82%
0
0%
03/31/2018
Teachers Advisors LLC
783,000
0.39%
0
0%
03/31/2018
Matthews International Capital Management LLC
502,100
0.25%
502,100
0%
06/30/2018
Amundi Ireland Ltd. (United Kingdom)
465,900
0.23%
465,900
0.02%
01/31/2018
SSgA Funds Management, Inc.
390,445
0.2%
0
0%
09/06/2018
S.E.A. Asset Management Pte. Ltd.
300,000
0.15%
300,000
2.89%
02/28/2018
Pheim Asset Management (Asia) Pte Ltd.
220,000
0.11%
220,000
1.69%
12/31/2017
APS Asset Management Pte Ltd.
186,400
0.09%
-831,200
0.06%
09/30/2017

About Tianjin Zhongxin Pharmaceutical Group Corp.

View Profile
Address
Zhongxin Building
Tianjin Tianjin 300193
China
Employees -
Website -
Updated 07/08/2019
Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. engages in the manufacture and sale of traditional Chinese medicine. Its business covers proprietary Chinese medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutritional supplements research and development and manufacturing, and commercial medicine. Its products include cardiovascular medicine, respiratory medicine, spleen and stomach medicine, cold medicine, cancer medication, gynecology, pediatrics and other multi-product groups.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.